药物对比
Ertugliflozin vs Repaglinide
比较 Ertugliflozin（SGLT2抑制剂）与 Repaglinide（格列奈类）治疗2型糖尿病。审视作用机制、副作用、低血糖风险及适用性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing add-on therapy after metformin for type 2 diabetes patients needing either SGLT2 benefits or prandial insulin stimulation.
结论
Ertugliflozin often provides broader benefits than Repaglinide but individual factors and safety profiles determine the better option.
全部药物对比